Abstract: A vaccine against Lyme disease, wherein it contains one or more monoclonal antibodies which are specific for the 31 kD antigen (OspA) or the 34 kD antigen (OspB) of Borrelia burgdorferi. The present invention also provides a process for obtaining this vaccine, as well as new monoclonal antibodies and antigens.
Type:
Grant
Filed:
March 20, 1995
Date of Patent:
November 11, 1997
Assignees:
Max-Planck-Gesellschaft zur Forderung der Wissenscaften E.V., Deutsches Krebsforschun Zentrum Stiftung des Offentlichen Rechts
Inventors:
Markus M. Simon, Ulrich E. Schaible, Klaus Eichmann, Michael Kramer, Wallich Reinhard